Clinical Trial Update: A Phase 1b Study of ARGX-111 in Patients With Advanced Cancer. [Phase 1]

View source ↗

Summary

Argenx reports completion of a Phase 1b trial of ARGX-111 in patients with advanced cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• ARGX-111

Snippet

Sponsor: argenx | Conditions: Cancer | Phase 1 | Status: COMPLETED